Leiden, The Netherlands, Aug. 20, 2013 (GLOBE NEWSWIRE) --Prosensa Holding N.V. (NASDAQ: RNA) today announced that theCompany will host a conference call and live audio webcast onWednesday, August 28, at 8:00am EDT to report its second quarterfinancial results and provide a corporate update.

In order to participate in the conference call, please dial1-877-249-9037 (US domestic) and refer to conference ID 6727193.International dial-in numbers and an audio webcast can be accessedunder "Events & Presentations" through the Investors &Media section of the Prosensa corporate website www.prosensa.com.

About Prosensa Holding N.V.

Prosensa (NASDAQ: RNA) is a Dutch biotechnology company engagedin the discovery and development of RNA-modulating therapeutics forthe treatment of genetic disorders. Its primary focus is on rareneuromuscular and neurodegenerative disorders with a large unmetmedical need, including Duchenne muscular dystrophy, myotonicdystrophy and Huntington's disease.

For more information, visit www.prosensa.com
CONTACT: Prosensa Holding N.V.         Celia Economides, Director IR & Corporate Communications         Phone: +1 917 975 1983         Email: c.economides@prosensa.nl

Prosensa Holding B.V. Logo